NAD+ Peptide Dosing Guide: Optimal Protocols

Overview

NAD+ is a research peptide discussed for its potential effects. This guide provides an educational overview of NAD+ dosing patterns based on published research and peptide community discussions, presented as a text-based dosage chart for discussion with a licensed healthcare provider. You can use our NAD+ dosage calculator → to plan protocol schedules and check reconstitution math — for educational purposes only.

What is NAD+?

NAD+ is a peptide compound discussed in research contexts.

Key characteristics:

• Mechanism:
• Route: intravenous, intramuscular, or subcutaneous injection
• Legal status: Not FDA-approved — research only
• Half-life: hours
• Category:

To calculate your protocol dosing, see our NAD+ dosage calculator →

NAD+ dosage chart

There is no established FDA-approved dose for NAD+. The chart below summarizes dosing patterns drawn from published research protocols and peptide community discussions. It is intended for educational reference only — not as a personal dosing plan or medical recommendation.

Protocol Phase	Dose Range	Route	Frequency	Duration	Use Case
Standard	1000 mg per day	IV / IM / SubQ	Daily or per protocol	4-8 weeks	NAD+ research protocol
Lower-dose exploratory	100 mg	SubQ / IM	Daily	2-4 weeks	Conservative start
Mid-range	500 mg	IV / IM	2-3x weekly	4-8 weeks	Common research dose
Higher-dose	1000 mg	IV infusion	Per protocol	4-8 weeks	Upper discussed range
Cycle break	No dose	—	—	As advised	Recovery period

For dose calculations, reconstitution math, and syringe unit conversions, see our NAD+ dosage calculator →

How NAD+ works

NAD+

Understanding the pharmacokinetic profile helps explain the dosing patterns. hours

For quick dose calculations based on these protocols, use our NAD+ dosage calculator →

Administration routes

NAD+ is commonly discussed as administered via intravenous, intramuscular, or subcutaneous injection in research literature. The choice of route affects bioavailability, onset, and duration of effect.

For reconstitution math and syringe unit calculations, see our NAD+ dosage calculator →

Cycle structure and timing

Research protocols for NAD+ typically follow a cycle structure with distinct phases: loading, maintenance, and recovery. The specific duration of each phase depends on the research context and should be discussed with a qualified professional.

Safety considerations

NAD+ is not FDA-approved for human use. All dosing information in this guide is presented for educational and research purposes only. Consult a licensed healthcare provider before considering any peptide protocol.

Frequently asked questions

See the FAQ section below for common questions about NAD+ dosing, administration, and research status.

Related Peptides

Frequently Asked Questions

Guías Relacionadas